https://www.selleckchem.com/products/sc75741.html 79, 95% confidence interval [CI] 0.63-0.99), while higher platelet counts were associated with a higher 30-day mortality (351-375 × 10 /L, aHR 1.34, 95% CI 1.07-1.68; 376-400× 10 /L, aHR 1.21, 95% CI 0.94-1.56). Platelet counts, even within the normal range, are associated with mortality in adult patients hospitalized for community-acquired pneumonia. Platelet counts, even within the normal range, are associated with mortality in adult patients hospitalized for community-acquired pneumonia.Despite numerous advances in cancer treatment, the global prevalence and cancer-related mortality remain high. Understanding tumor initiation and progression mechanisms are critical as it will lead to the development of interventions for improving the prognosis of cancer patients. The roles of long noncoding RNAs (lncRNAs) in cancer have attracted immense research interest. Growing evidence indicates that lncRNA regulator of reprogramming (linc-ROR), a well-studied RNA, regulates the progression of various cancers, such as lung cancer (LC), hepatocellular carcinoma (HCC), breast cancer (BC), colorectal cancer (CRC), pancreatic cancer (PC), papillary thyroid carcinoma (PTC), or esophageal squamous cell carcinoma (ESCC). linc-ROR promotes the proliferation, invasion, migration and chemoresistance of cancer cells. Herein, we reviewed current literature on the modulatory functions and mechanisms of linc-ROR in cancer development. We highlight new linc-ROR-related therapeutic strategies in cancer treatment. More and more studies show that platelets are closely related to the occurrence and development of tumors. This study aims to explore the predictive value of peripheral blood platelet count on the prognosis of breast cancer patients with ipsilateral supraclavicular lymph node (ISLN) metastasis. Eighty-five breast cancer patients with ISLN metastasis in the Affiliated Cancer Hospital of Zhengzhou University were collected retrospectiv